🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 122,22 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 148,73 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 2 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 13/06/2011 | 0,3626 USD |
| 11/03/2011 | 0,3626 USD |
| 13/12/2010 | 0,3626 USD |
| 13/09/2010 | 0,3626 USD |
| 11/06/2010 | 0,3626 USD |
| 11/03/2010 | 0,3626 USD |
| 11/12/2009 | 0,3626 USD |
| 02/09/2009 | 0,3626 USD |
| 04/06/2009 | 0,3626 USD |
| 04/03/2009 | 0,3626 USD |
| 03/12/2008 | 0,3626 USD |
| 03/09/2008 | 0,3626 USD |
| 04/06/2008 | 0,3626 USD |
| 05/03/2008 | 0,3626 USD |
| 05/12/2007 | 0,3626 USD |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 22/01/2016 | 49,08 | 49,37 | 48,62 | 49,00 | +0,84% | 1,54% | 11.331.814 |
| 21/01/2016 | 48,45 | 48,97 | 47,80 | 48,59 | +0,73% | 2,42% | 12.499.706 |
| 20/01/2016 | 47,99 | 48,68 | 47,04 | 48,23 | -1,54% | 3,42% | 16.684.579 |
| 19/01/2016 | 49,24 | 49,53 | 48,48 | 48,99 | +0,39% | 2,13% | 11.454.116 |
| 15/01/2016 | 48,19 | 48,95 | 47,81 | 48,80 | -1,27% | 2,38% | 16.233.939 |
| 14/01/2016 | 48,35 | 49,72 | 48,27 | 49,43 | +2,25% | 3,00% | 14.219.788 |
| 13/01/2016 | 49,53 | 49,68 | 48,26 | 48,34 | -2,13% | 2,85% | 17.340.837 |
| 12/01/2016 | 49,15 | 49,69 | 48,65 | 49,39 | +1,00% | 2,12% | 11.864.408 |
| 11/01/2016 | 48,90 | 49,18 | 48,29 | 48,90 | +0,33% | 1,81% | 15.057.035 |
| 08/01/2016 | 50,11 | 50,11 | 48,53 | 48,74 | -1,69% | 3,16% | 14.835.698 |
| 07/01/2016 | 49,16 | 49,92 | 49,08 | 49,58 | -0,88% | 1,71% | 13.330.560 |
| 06/01/2016 | 50,11 | 50,52 | 49,82 | 50,02 | -1,37% | 1,41% | 13.064.263 |
| 05/01/2016 | 50,37 | 51,02 | 50,26 | 50,72 | +1,28% | 1,52% | 11.607.124 |
| 04/01/2016 | 49,63 | 50,20 | 49,25 | 50,08 | -0,64% | 1,92% | 17.998.981 |
| 31/12/2015 | 50,38 | 50,85 | 50,25 | 50,40 | -0,81% | 1,19% | 8.690.959 |
| 30/12/2015 | 50,90 | 51,13 | 50,65 | 50,81 | -0,17% | 0,94% | 5.827.194 |
| 29/12/2015 | 50,54 | 51,15 | 50,49 | 50,90 | +0,95% | 1,32% | 6.925.708 |
| 28/12/2015 | 50,37 | 50,61 | 50,16 | 50,42 | -0,02% | 0,89% | 5.068.442 |
| 24/12/2015 | 50,37 | 50,70 | 50,20 | 50,43 | -0,25% | 0,99% | 3.123.145 |
| 23/12/2015 | 49,98 | 50,78 | 49,96 | 50,55 | +1,69% | 1,64% | 7.469.515 |
| 22/12/2015 | 49,63 | 49,84 | 48,93 | 49,71 | +0,44% | 1,83% | 13.830.351 |
| 21/12/2015 | 49,76 | 49,76 | 48,86 | 49,49 | +0,45% | 1,82% | 12.194.633 |
| 18/12/2015 | 49,76 | 49,92 | 49,25 | 49,27 | -1,94% | 1,36% | 22.114.686 |
| 17/12/2015 | 51,63 | 51,77 | 50,25 | 50,25 | -2,52% | 2,94% | 14.165.921 |
| 16/12/2015 | 50,97 | 51,63 | 50,57 | 51,55 | +2,12% | 2,08% | 10.494.986 |
| 15/12/2015 | 50,08 | 50,75 | 49,84 | 50,48 | +1,34% | 1,83% | 12.142.023 |
| 14/12/2015 | 49,76 | 49,96 | 49,28 | 49,81 | +0,10% | 1,36% | 12.575.162 |
| 11/12/2015 | 50,57 | 50,84 | 49,64 | 49,76 | -2,87% | 2,38% | 10.896.999 |
| 10/12/2015 | 50,59 | 51,51 | 50,40 | 51,23 | +1,65% | 2,19% | 12.001.591 |
| 09/12/2015 | 50,84 | 51,15 | 50,11 | 50,40 | -1,22% | 2,05% | 10.854.346 |